Cramer's Mad Dash on Estee Lauder: Let people panic sell, then buy the stock

Cramer's Mad Dash on Estee Lauder: Let people panic sell, then buy the stockПодробнее

Cramer's Mad Dash on Estee Lauder: Let people panic sell, then buy the stock

Cramer’s Mad Dash on Estee Lauder: Big inventory problems, but not their faultПодробнее

Cramer’s Mad Dash on Estee Lauder: Big inventory problems, but not their fault

Cramer’s Stop Trading: Estee LauderПодробнее

Cramer’s Stop Trading: Estee Lauder

Cramer’s Mad Dash: NXP has a really good portfolioПодробнее

Cramer’s Mad Dash: NXP has a really good portfolio

Cramer’s Mad Dash: VertivПодробнее

Cramer’s Mad Dash: Vertiv

Cramer’s Mad Dash on Carmax: Please do not sell thisПодробнее

Cramer’s Mad Dash on Carmax: Please do not sell this

Jim Cramer warns investors to not be swayed by market chatterПодробнее

Jim Cramer warns investors to not be swayed by market chatter

Cramer’s Mad Dash on Wynn: Chinese gamblers are backПодробнее

Cramer’s Mad Dash on Wynn: Chinese gamblers are back

Cramer’s Mad Dash: Lam ResearchПодробнее

Cramer’s Mad Dash: Lam Research

Is Estee Lauder Stock Done? Jim Cramer's Take #shortsПодробнее

Is Estee Lauder Stock Done? Jim Cramer's Take #shorts

Cramer’s Mad Dash: People betted on a shortfall with Chewy and didn't get itПодробнее

Cramer’s Mad Dash: People betted on a shortfall with Chewy and didn't get it

Cramer’s Mad Dash: UnileverПодробнее

Cramer’s Mad Dash: Unilever

Cramer’s Mad Dash: Johnson & JohnsonПодробнее

Cramer’s Mad Dash: Johnson & Johnson

Jim Cramer: Expect Estee Lauder to report 'blockbuster earnings'Подробнее

Jim Cramer: Expect Estee Lauder to report 'blockbuster earnings'

Cramer's Mad Dash: ASMLПодробнее

Cramer's Mad Dash: ASML

Cramer’s Mad Dash on On Holding: They are just smoking hotПодробнее

Cramer’s Mad Dash on On Holding: They are just smoking hot

Cramer’s Mad Dash: Affirm HoldingsПодробнее

Cramer’s Mad Dash: Affirm Holdings

Cramer’s Mad Dash: Ralph LaurenПодробнее

Cramer’s Mad Dash: Ralph Lauren

Cramer’s Mad Dash on Meta: They have trounced everyoneПодробнее

Cramer’s Mad Dash on Meta: They have trounced everyone

Recursion Pharmaceuticals CEO Chris Gibson goes one-on-one with Jim CramerПодробнее

Recursion Pharmaceuticals CEO Chris Gibson goes one-on-one with Jim Cramer

События